Why mAbs Matter
Quality Matters
FEBRUARY 6, 2025
As more monoclonal antibody (mAb) therapies are developed (1 in 3 new drugs are monoclonal antibodies1) and as patent exclusivity expires, these treatments are becoming more widely available. To understand monoclonal antibody drugs, its necessary to first know a little about how antibodies work in the bodys immune system.
52 
Let's personalize your content